{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:09:14Z","timestamp":1767704954916,"version":"3.48.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05343-z","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T14:41:59Z","timestamp":1763476919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and genomic characterization of brain metastasis in thyroid cancer"],"prefix":"10.1007","volume":"176","author":[{"given":"Branavan","family":"Manoranjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelalem","family":"Demere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne S.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke R. G.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon S.","family":"Imber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Michael","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren S.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson S.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"5343_CR1","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillekas","year":"2019","unstructured":"Dillekas H, Rogers MS, Straume O (2019) Are 90% of deaths from cancer caused by metastases? Cancer Med 8:5574\u20135576. https:\/\/doi.org\/10.1002\/cam4.2474","journal-title":"Cancer Med"},{"key":"5343_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1210\/js.2018-00241","volume":"3","author":"CJ Gomes-Lima","year":"2019","unstructured":"Gomes-Lima CJ, Wu D, Rao SN, Punukollu S, Hritani R, Zeymo A, Deeb H, Mete M, Aulisi EF, Van Nostrand D, Jonklaas J, Wartofsky L, Burman KD (2019) Brain metastases from differentiated thyroid carcinoma: Prevalence, current Therapies, and outcomes. J Endocr Soc 3:359\u2013371. https:\/\/doi.org\/10.1210\/js.2018-00241","journal-title":"J Endocr Soc"},{"key":"5343_CR3","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jcem.82.11.4386","volume":"82","author":"AC Chiu","year":"1997","unstructured":"Chiu AC, Delpassand ES, Sherman SI (1997) Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab 82:3637\u20133642. https:\/\/doi.org\/10.1210\/jcem.82.11.4386","journal-title":"J Clin Endocrinol Metab"},{"key":"5343_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1089\/thy.2013.0061","volume":"24","author":"B Henriques de Figueiredo","year":"2014","unstructured":"Henriques de Figueiredo B, Godbert Y, Soubeyran I, Carrat X, Lagarde P, Cazeau AL, Italiano A, Sargos P, Kantor G, Loiseau H, Bonichon F (2014) Brain metastases from thyroid carcinoma: a retrospective study of 21 patients. Thyroid 24:270\u2013276. https:\/\/doi.org\/10.1089\/thy.2013.0061","journal-title":"Thyroid"},{"key":"5343_CR5","doi-asserted-by":"publisher","first-page":"730025","DOI":"10.3389\/fendo.2021.730025","volume":"12","author":"T Wu","year":"2021","unstructured":"Wu T, Jiao Z, Li Y, Peng J, Yao F, Chen W, Yang A (2021) Brain metastases from differentiated thyroid carcinoma: A retrospective study of 22 patients. Front Endocrinol (Lausanne) 12:730025. https:\/\/doi.org\/10.3389\/fendo.2021.730025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5343_CR6","doi-asserted-by":"publisher","unstructured":"Toraih EA, Hussein MH, Zerfaoui M, Attia AS, Marzouk Ellythy A, Mostafa A, Ruiz EML, Shama MA, Russell JO, Randolph GW, Kandil E (2021) Site-specific metastasis and survival in papillary thyroid cancer: the importance of brain and multi-organ disease. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13071625","DOI":"10.3390\/cancers13071625"},{"key":"5343_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamaoto.2022.5045","volume":"149","author":"SS Wu","year":"2023","unstructured":"Wu SS, Lamarre ED, Yalamanchali A, Brauer PR, Hong H, Reddy CA, Yilmaz E, Woody N, Ku JA, Prendes B, Burkey B, Nasr C, Skugor M, Heiden K, Chute DJ, Knauf JA, Campbell SR, Koyfman SA, Geiger JL, Scharpf J (2023) Association of treatment strategies and tumor characteristics with overall survival among patients with anaplastic thyroid cancer: A Single-Institution 21-Year experience. JAMA Otolaryngol Head Neck Surg 149:300\u2013309. https:\/\/doi.org\/10.1001\/jamaoto.2022.5045","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"5343_CR8","doi-asserted-by":"publisher","first-page":"e0154739","DOI":"10.1371\/journal.pone.0154739","volume":"11","author":"J Choi","year":"2016","unstructured":"Choi J, Kim JW, Keum YS, Lee IJ (2016) The largest known survival analysis of patients with brain metastasis from thyroid cancer based on prognostic groups. PLoS ONE 11:e0154739. https:\/\/doi.org\/10.1371\/journal.pone.0154739","journal-title":"PLoS ONE"},{"key":"5343_CR9","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0087","author":"J Yoo","year":"2022","unstructured":"Yoo J, Kim HJ, Kim SM, Park HH (2022) Prognostic factors to predict the efficacy of surgical interventions against brain metastasis secondary to thyroid cancer. Eur Thyroid J 11. https:\/\/doi.org\/10.1530\/ETJ-22-0087","journal-title":"Eur Thyroid J 11"},{"key":"5343_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/RLU.0000000000002618","volume":"44","author":"JR Osborne","year":"2019","unstructured":"Osborne JR, Kondraciuk JD, Rice SL, Zhou X, Knezevic A, Spratt DE, Sabra M, Larson SM, Grewal RK (2019) Thyroid cancer brain metastasis: survival and genomic characteristics of a large tertiary care cohort. Clin Nucl Med 44:544\u2013549. https:\/\/doi.org\/10.1097\/RLU.0000000000002618","journal-title":"Clin Nucl Med"},{"key":"5343_CR11","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s00701-015-2611-5","volume":"157","author":"HS Lee","year":"2015","unstructured":"Lee HS, Yoo H, Lee SH, Gwak HS, Shin SH (2015) Clinical characteristics and follow-up of intracranial metastases from thyroid cancer. Acta Neurochir (Wien) 157:2185\u20132194. https:\/\/doi.org\/10.1007\/s00701-015-2611-5","journal-title":"Acta Neurochir (Wien)"},{"key":"5343_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10585-023-10208-8","volume":"40","author":"L Wolff","year":"2023","unstructured":"Wolff L, Steindl A, Popov P, Dieckmann K, Gatterbauer B, Widhalm G, Berghoff AS, Preusser M, Raderer M, Kiesewetter B (2023) Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer. Clin Exp Metastasis 40:217\u2013226. https:\/\/doi.org\/10.1007\/s10585-023-10208-8","journal-title":"Clin Exp Metastasis"},{"key":"5343_CR13","doi-asserted-by":"publisher","unstructured":"Esmaeilzadeh M, Atallah O, Muller JA, Bengel F, Polemikos M, Heissler HE, Krauss JK (2024) Brain metastases from thyroid carcinoma: prognostic factors and outcomes. Cancers (Basel) 16. https:\/\/doi.org\/10.3390\/cancers16132371","DOI":"10.3390\/cancers16132371"},{"key":"5343_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00428-013-1394-4","volume":"462","author":"FC Tahmasebi","year":"2013","unstructured":"Tahmasebi FC, Farmer P, Powell SZ, Aldape KD, Fuller GN, Patel S, Hollis P, Chalif D, Eisenberg MB, Li JY (2013) Brain metastases from papillary thyroid carcinomas. Virchows Arch 462:473\u2013480. https:\/\/doi.org\/10.1007\/s00428-013-1394-4","journal-title":"Virchows Arch"},{"key":"5343_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11060-008-9783-2","volume":"93","author":"IY Kim","year":"2009","unstructured":"Kim IY, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2009) Gamma knife radiosurgery for metastatic brain tumors from thyroid cancer. J Neurooncol 93:355\u2013359. https:\/\/doi.org\/10.1007\/s11060-008-9783-2","journal-title":"J Neurooncol"},{"key":"5343_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/cncr.11488","volume":"98","author":"RR McWilliams","year":"2003","unstructured":"McWilliams RR, Giannini C, Hay ID, Atkinson JL, Stafford SL, Buckner JC (2003) Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer 98:356\u2013362. https:\/\/doi.org\/10.1002\/cncr.11488","journal-title":"Cancer"},{"key":"5343_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1023\/a:1006468527935","volume":"51","author":"M Salvati","year":"2001","unstructured":"Salvati M, Frati A, Rocchi G, Masciangelo R, Antonaci A, Gagliardi FM, Delfini R (2001) Single brain metastasis from thyroid cancer: report of twelve cases and review of the literature. J Neurooncol 51:33\u201340. https:\/\/doi.org\/10.1023\/a:1006468527935","journal-title":"J Neurooncol"},{"key":"5343_CR18","doi-asserted-by":"publisher","first-page":"e1732","DOI":"10.1200\/OP.22.00258","volume":"18","author":"NS Moss","year":"2022","unstructured":"Moss NS, El Ahmadieh TY, Brown S, Chen J, Imber BS, Pike L, Reiner AS, Panageas KS, Brennan C, Tabar V, Beal K (2022) Integrated multidisciplinary brain metastasis care reduces patient visits and shortens time to adjuvant irradiation. JCO Oncol Pract 18:e1732\u2013e1738. https:\/\/doi.org\/10.1200\/OP.22.00258","journal-title":"JCO Oncol Pract"},{"key":"5343_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"key":"5343_CR20","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"key":"5343_CR21","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, Li X, Ochoa A, Zhao G, Lai B, Abeshouse A, Baiceanu D, Ciftci E, Dogrusoz U, Dufilie A, Erkoc Z, Garcia Lara E, Fu Z, Gross B, Haynes C, Heath A, Higgins D, Jagannathan P, Kalletla K, Kumari P, Lindsay J, Lisman A, Leenknegt B, Lukasse P, Madela D, Madupuri R, van Nierop P, Plantalech O, Quach J, Resnick AC, Rodenburg SYA, Satravada BA, Schaeffer F, Sheridan R, Singh J, Sirohi R, Sumer SO, van Hagen S, Wang A, Wilson M, Zhang H, Zhu K, Rusk N, Brown S, Lavery JA, Panageas KS, Rudolph JE, LeNoue-Newton ML, Warner JL, Guo X, Hunter-Zinck H, Yu TV, Pilai S, Nichols C, Gardos SM, Philip J, Aacr Project Genie Bpc Core Team APGC, Kehl KL, Riely GJ, Schrag D, Lee J, Fiandalo MV, Sweeney SM, Pugh TJ, Sander C, Cerami E, Gao J, Schultz N (2023) Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Res 83:3861\u20133867. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0816","journal-title":"Cancer Res"},{"key":"5343_CR22","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","volume":"24","author":"N Pozdeyev","year":"2018","unstructured":"Pozdeyev N, Gay LM, Sokol ES, Hartmaier R, Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, Schweppe RE, Fishbein L, Ross JS, Haugen BR, Bowles DW (2018) Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers. Clin Cancer Res 24:3059\u20133068. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0373","journal-title":"Clin Cancer Res"},{"key":"5343_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4103\/ijem.IJEM_321_19","volume":"23","author":"M Rashid","year":"2019","unstructured":"Rashid M, Agarwal A, Pradhan R, George N, Kumari N, Sabaretnam M, Chand G, Mishra A, Agarwal G, Mishra SK (2019) Genetic alterations in anaplastic thyroid carcinoma. Indian J Endocrinol Metab 23:480\u2013485. https:\/\/doi.org\/10.4103\/ijem.IJEM_321_19","journal-title":"Indian J Endocrinol Metab"},{"key":"5343_CR24","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1210\/clinem\/dgae271","volume":"109","author":"S Toda","year":"2024","unstructured":"Toda S, Hiroshima Y, Iwasaki H, Masudo K (2024) Genomic landscape and clinical features of advanced thyroid carcinoma: A National database study in Japan. J Clin Endocrinol Metab 109:2784\u20132792. https:\/\/doi.org\/10.1210\/clinem\/dgae271","journal-title":"J Clin Endocrinol Metab"},{"key":"5343_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00268-016-3405-5","volume":"40","author":"F Saito","year":"2016","unstructured":"Saito F, Uruno T, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K (2016) Prognosis after brain metastasis from differentiated thyroid carcinoma. World J Surg 40:574\u2013581. https:\/\/doi.org\/10.1007\/s00268-016-3405-5","journal-title":"World J Surg"},{"key":"5343_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1200\/JCO.2017.75.9589","volume":"36","author":"PD Brown","year":"2018","unstructured":"Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V (2018) Whole-Brain radiotherapy for brain metastases: evolution or revolution? J Clin Oncol 36:483\u2013491. https:\/\/doi.org\/10.1200\/JCO.2017.75.9589","journal-title":"J Clin Oncol"},{"key":"5343_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40:492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314","journal-title":"J Clin Oncol"},{"key":"5343_CR28","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037\u20131044. https:\/\/doi.org\/10.1016\/S1470-2045(09)70263-3","journal-title":"Lancet Oncol"},{"key":"5343_CR29","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1016\/j.wneu.2022.12.070","volume":"171","author":"J Byun","year":"2023","unstructured":"Byun J, Song SW, Kim YH, Hong CK, Kim JH, Kim JH (2023) Treatment outcome of gamma knife radiosurgery for brain metastasis from thyroid cancer: favorable local control but poor survival. World Neurosurg 171:e605\u2013e610. https:\/\/doi.org\/10.1016\/j.wneu.2022.12.070","journal-title":"World Neurosurg"},{"key":"5343_CR30","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR (2023) Thyroid cancer. Lancet 401:1531\u20131544. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X","journal-title":"Lancet"},{"key":"5343_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jso.27883","author":"V Harries","year":"2024","unstructured":"Harries V, Eagan A, Tuttle RM, Shaha AR, Wong RJ, Shah JP, Patel SG, Brennan C, Ganly I (2024) The surgical management of intracranial metastasis secondary to follicular Cell-Derived thyroid carcinoma. J Surg Oncol. https:\/\/doi.org\/10.1002\/jso.27883","journal-title":"J Surg Oncol"},{"key":"5343_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.nec.2020.06.002","volume":"31","author":"KKH Yu","year":"2020","unstructured":"Yu KKH, Patel AR, Moss NS (2020) The role of stereotactic biopsy in brain metastases. Neurosurg Clin N Am 31:515\u2013526. https:\/\/doi.org\/10.1016\/j.nec.2020.06.002","journal-title":"Neurosurg Clin N Am"},{"key":"5343_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41568-023-00598-y","volume":"23","author":"JA Fagin","year":"2023","unstructured":"Fagin JA, Krishnamoorthy GP, Landa I (2023) Pathogenesis of cancers derived from thyroid follicular cells. Nat Rev Cancer 23:631\u2013650. https:\/\/doi.org\/10.1038\/s41568-023-00598-y","journal-title":"Nat Rev Cancer"},{"key":"5343_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676\u2013690. https:\/\/doi.org\/10.1016\/j.cell.2014.09.050","journal-title":"Cell"},{"key":"5343_CR35","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/S1470-2045(16)30166-8","volume":"17","author":"MS Brose","year":"2016","unstructured":"Brose MS, Cabanillas ME, Cohen EE, Wirth LJ, Riehl T, Yue H, Sherman SI, Sherman EJ (2016) Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial. Lancet Oncol 17:1272\u20131282. https:\/\/doi.org\/10.1016\/S1470-2045(16)30166-8","journal-title":"Lancet Oncol"},{"key":"5343_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","volume":"36","author":"V Subbiah","year":"2018","unstructured":"Subbiah V, Kreitman RJ, Wainberg ZA, Cho JY, Schellens JHM, Soria JC, Wen PY, Zielinski C, Cabanillas ME, Urbanowitz G, Mookerjee B, Wang D, Rangwala F, Keam B (2018) Dabrafenib and Trametinib treatment in patients with locally advanced or metastatic BRAF V600-Mutant anaplastic thyroid cancer. J Clin Oncol 36:7\u201313. https:\/\/doi.org\/10.1200\/JCO.2017.73.6785","journal-title":"J Clin Oncol"},{"key":"5343_CR37","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1038\/s41598-017-04948-3","volume":"7","author":"N Fakhruddin","year":"2017","unstructured":"Fakhruddin N, Jabbour M, Novy M, Tamim H, Bahmad H, Farhat F, Zaatari G, Aridi T, Kriegshauser G, Oberkanins C, Mahfouz R (2017) BRAF and NRAS mutations in papillary thyroid carcinoma and concordance in BRAF mutations between primary and corresponding lymph node metastases. Sci Rep 7:4666. https:\/\/doi.org\/10.1038\/s41598-017-04948-3","journal-title":"Sci Rep"},{"key":"5343_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1406470","volume":"372","author":"M Schlumberger","year":"2015","unstructured":"Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, Dutcus CE, de las Heras B, Zhu J, Sherman SI (2015) Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med 372:621\u2013630. https:\/\/doi.org\/10.1056\/NEJMoa1406470","journal-title":"N Engl J Med"},{"key":"5343_CR39","doi-asserted-by":"publisher","unstructured":"Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Pena C, Molnar I, Schlumberger MJ, Investigators D (2014) Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet 384:319\u2013328 https:\/\/doi.org\/10.1016\/S0140-6736(14)60421-9","DOI":"10.1016\/S0140-6736(14)60421-9"},{"key":"5343_CR40","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1089\/thy.2011.0419","volume":"22","author":"Y Shen","year":"2012","unstructured":"Shen Y, Ruan M, Luo Q, Yu Y, Lu H, Zhu R, Chen L (2012) Brain metastasis from follicular thyroid carcinoma: treatment with Sorafenib. Thyroid 22:856\u2013860. https:\/\/doi.org\/10.1089\/thy.2011.0419","journal-title":"Thyroid"},{"key":"5343_CR41","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/ccr3.3900","volume":"9","author":"F Pitoia","year":"2021","unstructured":"Pitoia F (2021) Complete response to larotrectinib treatment in a patient with papillary thyroid cancer harboring an ETV6-NTRK3 gene fusion. Clin Case Rep 9:1905\u20131912. https:\/\/doi.org\/10.1002\/ccr3.3900","journal-title":"Clin Case Rep"},{"key":"5343_CR42","doi-asserted-by":"publisher","unstructured":"Rendl G, Sipos B, Becherer A, Sorko S, Trummer C, Raderer M, Hitzl W, Ardelt M, Gallowitsch HJ, Pirich C (2020) Real-World data for lenvatinib in Radioiodine-Refractory differentiated thyroid cancer (RELEVANT): A retrospective multicentric analysis of clinical practice in Austria. Int J Endocrinol 2020(8834148). https:\/\/doi.org\/10.1155\/2020\/8834148","DOI":"10.1155\/2020\/8834148"},{"key":"5343_CR43","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.annonc.2021.12.014","volume":"33","author":"V Subbiah","year":"2022","unstructured":"Subbiah V, Kreitman RJ, Wainberg ZA, Cho JY, Schellens JHM, Soria JC, Wen PY, Zielinski CC, Cabanillas ME, Boran A, Ilankumaran P, Burgess P, Romero Salas T, Keam B (2022) Dabrafenib plus Trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study. Ann Oncol 33:406\u2013415. https:\/\/doi.org\/10.1016\/j.annonc.2021.12.014","journal-title":"Ann Oncol"},{"key":"5343_CR44","first-page":"5888","volume":"11","author":"B Lin","year":"2019","unstructured":"Lin B, Ma H, Ma M, Zhang Z, Sun Z, Hsieh IY, Okenwa O, Guan H, Li J, Lv W (2019) The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis. Am J Transl Res 11:5888\u20135896","journal-title":"Am J Transl Res"},{"key":"5343_CR45","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","volume":"18","author":"MA Davies","year":"2017","unstructured":"Davies MA, Saiag P, Robert C, Grob JJ, Flaherty KT, Arance A, Chiarion-Sileni V, Thomas L, Lesimple T, Mortier L, Moschos SJ, Hogg D, Marquez-Rodas I, Del Vecchio M, Lebbe C, Meyer N, Zhang Y, Huang Y, Mookerjee B, Long GV (2017) Dabrafenib plus Trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Lancet Oncol 18:863\u2013873. https:\/\/doi.org\/10.1016\/S1470-2045(17)30429-1","journal-title":"Lancet Oncol"},{"key":"5343_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1530\/EC-16-0049","volume":"5","author":"J Simoes-Pereira","year":"2016","unstructured":"Simoes-Pereira J, Macedo D, Bugalho MJ (2016) Clinical outcomes of a cohort of patients with central nervous system metastases from thyroid cancer. Endocr Connect 5:82\u201388. https:\/\/doi.org\/10.1530\/EC-16-0049","journal-title":"Endocr Connect"},{"key":"5343_CR47","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","volume":"15","author":"M Choi","year":"2016","unstructured":"Choi M, Kipps T, Kurzrock R (2016) ATM mutations in cancer: therapeutic implications. Mol Cancer Ther 15:1781\u20131791. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0945","journal-title":"Mol Cancer Ther"},{"key":"5343_CR48","doi-asserted-by":"publisher","unstructured":"Nguyen B, Fong C, Luthra A, Smith SA, DiNatale RG, Nandakumar S, Walch H, Chatila WK, Madupuri R, Kundra R, Bielski CM, Mastrogiacomo B, Donoghue MTA, Boire A, Chandarlapaty S, Ganesh K, Harding JJ, Iacobuzio-Donahue CA, Razavi P, Reznik E, Rudin CM, Zamarin D, Abida W, Abou-Alfa GK, Aghajanian C, Cercek A, Chi P, Feldman D, Ho AL, Iyer G, Janjigian YY, Morris M, Motzer RJ, O\u2019Reilly EM, Postow MA, Raj NP, Riely GJ, Robson ME, Rosenberg JE, Safonov A, Shoushtari AN, Tap W, Teo MY, Varghese AM, Voss M, Yaeger R, Zauderer MG, Abu-Rustum N, Garcia-Aguilar J, Bochner B, Hakimi A, Jarnagin WR, Jones DR, Molena D, Morris L, Rios-Doria E, Russo P, Singer S, Strong VE, Chakravarty D, Ellenson LH, Gopalan A, Reis-Filho JS, Weigelt B, Ladanyi M, Gonen M, Shah SP, Massague J, Gao J, Zehir A, Berger MF, Solit DB, Bakhoum SF, Sanchez-Vega F, Schultz N (2022) Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell 185:563\u2013575 e511 https:\/\/doi.org\/10.1016\/j.cell.2022.01.003","DOI":"10.1016\/j.cell.2022.01.003"},{"key":"5343_CR49","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/jamaoncol.2022.1928","volume":"8","author":"NS Moss","year":"2022","unstructured":"Moss NS, Beal K, Tabar V (2022) Brain Metastasis-A distinct oncologic disease best served by an integrated multidisciplinary team approach. JAMA Oncol 8:1252\u20131254. https:\/\/doi.org\/10.1001\/jamaoncol.2022.1928","journal-title":"JAMA Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05343-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05343-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05343-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:34:12Z","timestamp":1767702852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05343-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5343"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05343-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by MSK Institutional Review Board (IRB 16-1531).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}